Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ottavio de Cobelli

Showing results (61-70 of 427) with videos related to

Pageof 43
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 25, 2019
Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approachesFrancesco Alessandro Mistretta, Antonio Galfano, Ettore Di Trapani, et al.
Urologic Oncology|January 11, 2015
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomyFrancesco Cantiello, Giorgio Ivan Russo, Matteo Ferro, et al.
Andrologia|May 1, 2020
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapyGennaro Musi, Gabriele Cozzi, Francesco Alessandro Mistretta, et al.
Future Oncology (London, England)|August 5, 2017
Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/mlIulia Andras, Nicolae Crisan, Stefan Vesa, et al.
Journal of Contemporary Brachytherapy|December 10, 2020
Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case reportAndrea Vavassori, Stefano Durante, Matteo Augugliaro, et al.
Journal of Endourology|January 24, 2018
Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological OutcomesGennaro Musi, Francesco A Mistretta, Carlo Marenghi, et al.
Anticancer Research|February 11, 2015
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosineMatteo Ferro, Giuseppe Lucarelli, Dario Bruzzese, et al.
International Journal of Molecular Sciences|February 15, 2020
Beyond PSA: The Role of Prostate Health Index (phi)Matteo Ferro, Ottavio De Cobelli, Giuseppe Lucarelli, et al.
Medicine|December 26, 2015
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational StudyGiuseppe Di Lorenzo, Carlo Buonerba, Teresa Bellelli, et al.
BJU International|July 24, 2009
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysisBernardo Rocco, Barbara A Jereczek-Fossa, Deliu-Victor Matei, et al.
Pageof 43

Showing results (61-70 of 427) with videos related to

Sort By:
Pageof 43
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 25, 2019
Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approachesFrancesco Alessandro Mistretta, Antonio Galfano, Ettore Di Trapani, et al.
Urologic Oncology|January 11, 2015
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomyFrancesco Cantiello, Giorgio Ivan Russo, Matteo Ferro, et al.
Andrologia|May 1, 2020
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapyGennaro Musi, Gabriele Cozzi, Francesco Alessandro Mistretta, et al.
Future Oncology (London, England)|August 5, 2017
Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/mlIulia Andras, Nicolae Crisan, Stefan Vesa, et al.
Journal of Contemporary Brachytherapy|December 10, 2020
Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case reportAndrea Vavassori, Stefano Durante, Matteo Augugliaro, et al.
Journal of Endourology|January 24, 2018
Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological OutcomesGennaro Musi, Francesco A Mistretta, Carlo Marenghi, et al.
Anticancer Research|February 11, 2015
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosineMatteo Ferro, Giuseppe Lucarelli, Dario Bruzzese, et al.
International Journal of Molecular Sciences|February 15, 2020
Beyond PSA: The Role of Prostate Health Index (phi)Matteo Ferro, Ottavio De Cobelli, Giuseppe Lucarelli, et al.
Medicine|December 26, 2015
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational StudyGiuseppe Di Lorenzo, Carlo Buonerba, Teresa Bellelli, et al.
BJU International|July 24, 2009
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysisBernardo Rocco, Barbara A Jereczek-Fossa, Deliu-Victor Matei, et al.
Pageof 43